Table 1.
Correlation of CD44v10 expression with the clinicopathological feature of primary breast cancer patients
| Characteristic parameter | N | CD44v10 expression (mean IOD) ∗10-2 | Median | p-value |
|---|---|---|---|---|
| Age | 0.604 | |||
| < 50 years | 24 | 2.622 ± 3.987 | 0.685 | |
| ≥ 50 years | 72 | 3.036 ± 3.007 | 2.078 | |
| Histopathological grade | 0.035 | |||
| I-II | 63 | 2.417 ± 2.845 | 1.304 | |
| III | 33 | 3.894 ± 3.757 | 2.965 | |
| Tumor size | 0.843 | |||
| ≤ 2 cm | 15 | 3.08 ± 2.973 | 2.273 | |
| >2 cm | 81 | 2.896 ± 3.315 | 1.370 | |
| Lymph node status | 0.950 | |||
| Negative | 31 | 2.894 ± 2.306 | 2.964 | |
| Positive | 65 | 2.939 ± 3.633 | 1.302 | |
| TNM stage | 0.006 | |||
| Early stage (I-II) | 64 | 2.283 ± 2.690 | 1.259 | |
| Advanced stage (III) | 32 | 4.028 ± 3.877 | 3.187 |
The bold value indicates a significant difference.
Abbreviations: N, number; TNM, Tumor, Lymph Node, Metastasis.